Home » Pfizer » UBS lowers Pfizer (NYSE:PFE) Price Target of $34 UBS lowers Pfizer (NYSE:PFE) Price Target of $34 Posted on October 21, 2023 By legume No Comments on UBS lowers Pfizer (NYSE:PFE) Price Target of $34 UBS analyst Colin Bristow assumes Pfizer (NYSE:PFE) with a Neutral rating and lowers Price Target of $34. Health Care Tags:Pfizer